Titre:
  • Effectiveness of ustekinumab dose escalation in Crohn's disease patients with insufficient response to standard-dose subcutaneous maintenance therapy.
Auteur:Kopylov, Uri; Hanzel, Jurij; Liefferinckx, Claire; De Marco, Davide; Imperatore, Nicola; Plevris, Nikolas; Baston-Rey, Iria; Harris, Richard J; Truyens, Marie; Domislovic, Viktor; Vavricka, Stephan; Biemans, Vince; Myers, Sally; Sebastian, Shaji; Ben-Horin, Shomron; González Lama, Yago; Gilletta, Cyrielle; Ariella, Bar-Gil Shitrit; Zelinkova, Zuzana; Weisshof, Roni; Storan, Darragh; Zittan, Eran; Farkas, Klaudia; Molnar, Tamas; Franchimont, Denis; Cremer, Anneline; Afif, Waqqas; Castiglione, Fabiana; Lees, Charles; Barreiro-de Acosta, Manuel; Lobaton, Triana; Doherty, Glen; Krznaric, Zeljko; Pierik, Marieke; Hoentjen, Frank; Drobne, David
Informations sur la publication:Alimentary pharmacology & therapeutics, 52, 1, page (135-142)
Statut de publication:Publié, 2020-07-01
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Administration, Intravenous
Adult
Crohn Disease -- drug therapy
Female
Gastrointestinal Agents -- administration & dosage
Humans
Injections, Subcutaneous
Maintenance Chemotherapy
Male
Middle Aged
Remission Induction
Retrospective Studies
Treatment Outcome
Ustekinumab -- administration & dosage
Langue:Anglais
Identificateurs:urn:issn:0269-2813
info:doi/10.1111/apt.15784
info:pmid/32412134